From: RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy
Independent association with increasing RANKL expression ( P value) | Independent association with increasing RANK expression ( P value) | |
---|---|---|
Diagnosis during pregnancy (yes vs. no) | <0.001 | 0.67 |
Tumor size (≤2 cm vs. >2 cm) | 0.23 | 0.87 |
Nodal involvement (negative vs. positive) | 0.15 | 0.19 |
Histological grade (I vs. II vs. III) | 0.09 | 0.7 |
Breast cancer subtypes (luminal A vs. luminal B vs. HER2 vs. triple negative) | 0.75 | <0.001 |
Increasing progesterone receptor expression by IHC (continuous variable) | <0.001 | 0.17 |
Neoadjuvant chemotherapy (yes vs. no) | 0.69 | <0.001 |